SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001842952-24-000029
Filing Date
2024-04-26
Accepted
2024-04-26 16:16:15
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-26

Document Format Files

Seq Description Document Type Size
1 ARS cntx10-kdec312023.pdf ARS 12500702
  Complete submission text file 0001842952-24-000029.txt   17210124
Mailing Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103 267-225-7416
Context Therapeutics Inc. (Filer) CIK: 0001842952 (see all company filings)

IRS No.: 863738787 | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-40654 | Film No.: 24884001
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)